These success, together with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 help the idea of focusing on ACKR3 as a unique approach to modulate the opioid system, which could open up new therapeutic avenues for opioid-similar Issues. (two) The health practitioner https://jimmyy925lmi9.webdesign96.com/profile